University of Texas Medical Branch — Nucleic Acid Antiviral Testing
Verified[Human Health and Wellbeing] Open Philanthropy recommended a gift of $200,000 to Professor Kent Tseng of the University of Texas Medical Branch (UTMB) to support a test of the utility of a locked nucleic acid (LNA) as an antiviral drug for influenza A virus. Dr. Tseng has access to BSL3-enhanced and BSL4 laboratories, and will test the drug against the highly pathogenic pandemic H5N1 virus in several animal species. R&D done by Jeffrey Glenn's group predicts that the LNA will inhibit the growth of all influenza A viruses, including H5N1 strains. This gift was funded via a request for proposals through the Pandemic Antiviral Discovery Initiative. It falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.
Other Grants by Coefficient Giving
2625| Grant | Recipient | Amount | Date |
|---|---|---|---|
| Janaagraha — Air Quality Grants Assessment | $195K | Dec 2024 | |
| Futurewise — Housing Advocacy in Washington | $450K | Apr 2023 | |
| Exscientia — Agonists for Interferon Lambda | $2.3M | Sep 2023 | |
| Kurzgesagt — Short-form Video Content | $3M | Mar 2022 | |
| Kurzgesagt — Video Production (2023) | $1.7M | May 2023 | |
| Kurzgesagt — Video Creation and Translation | $2.6M | Dec 2021 | |
| Lightcone Infrastructure – General Support | Lighthaven (Event Venue) | $4.5M | Sep 2022 |
| Lightcone Infrastructure — General Support (2023) | Lighthaven (Event Venue) | $3M | Oct 2023 |
| Conjecture — Cybersecurity Bootcamp | Conjecture | $223K | Jun 2025 |
| Conjecture — AI Safety Technical Program | Conjecture | $224K | May 2023 |